394 results on '"Kobayashi, Hiroya"'
Search Results
52. Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site
53. Visinin-Like Protein-3 Modulates the Interaction Between Cytochrome b 5 and NADH-Cytochrome b 5 Reductase in a Ca2+-Dependent Manner
54. Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury
55. IFN ‐α/β‐mediated NK2R expression is related to the malignancy of colon cancer cells
56. A tumor metastasis‐associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity
57. IFN-alpha/beta-mediated NK2R expression is related to the malignancy of colon cancer cells
58. Celecoxib promotes the efficacy of STING‐targeted therapy by increasing antitumor CD8+ T‐cell functions via modulating glucose metabolism of CD11b+Ly6G+ cells.
59. Mitogen‐activated protein kinase inhibition augments the T cell response against HOXB7‐expressing tumor through human leukocyte antigen upregulation.
60. CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma
61. Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma
62. Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53
63. Assessment of the change in cetuximab-induced antibody-dependent cellular cytotoxicity activity of natural killer cells by steroid
64. Neuropeptide signaling through neurokinin-1 and neurokinin-2 receptors augments antigen presentation by human dendritic cells
65. CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
66. A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitope
67. The Fungal Metabolite (+)-Terrein Abrogates Ovariectomy-Induced Bone Loss and Receptor Activator of Nuclear Factor-κB Ligand–Induced Osteoclastogenesis by Suppressing Protein Kinase-C α/βII Phosphorylation
68. A stealth antigen SPESP1, which is epigenetically silenced in tumors, is a suitable target for cancer immunotherapy
69. Additional file 1 of Severe spruelike enteropathy and collagenous colitis caused by olmesartan
70. The Fungal Metabolite (+)-Terrein Abrogates Ovariectomy-Induced Bone Loss and Receptor Activator of Nuclear Factor-kappa B Ligand-Induced Osteoclastogenesis by Suppressing Protein Kinase-C alpha/beta II Phosphorylation
71. Peptide epitope identification for tumor-reactive CD4 T cells
72. Characterization of human CD4 helper T cell responses against Aurora kinase A
73. Focal adhesion kinase as an immunotherapeutic target
74. Promiscuous Peptides on the Nontypeable Haemophilus Influenzae P6 Outer Membrane Protein
75. The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer
76. Defining MHC class II T helper epitopes for WT1 tumor antigen
77. Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma
78. Contribution of long-chain fatty acid to induction of myeloid-derived suppressor cell (MDSC)-like cells – induction of MDSC by lipid vesicles (liposome)
79. Existence of MHC class I-restricted alloreactive CD4+ T cells reacting with peptide transporter-deficient cells
80. Identification of human T-cell epitopes and highly immunogenic analog peptides on the non-typeable Haemophilus influenzae P6 outer membrane protein
81. Abstract 6622: The identification of extranodal NK/T cell lymphoma-associated antigen for helper T cell-based immunotherapy
82. The fungal metabolite (+)-terrein abrogates osteoclast differentiation via suppression of the RANKL signaling pathway through NFATc1
83. Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma
84. Role of Nitric Oxide in the Change of 5-Hydroxytryptamine Synthesis in the Intestine by a Consecutive Administration of Methotrexate to Rats
85. A Case of Secretory Carcinoma of the Submandibular Gland Harboring an ETV6-X Fusion Gene
86. Six-Transmembrane Epithelial Antigen of the Prostate as an Immunotherapeutic Target for Renal Cell and Bladder Cancer
87. Analysis of anchor residues in a naturally processed HLA-DR53 ligand
88. Decreased Expression of Retinoid X Receptor Isoforms in Human Thyroid Carcinomas
89. THE USE OF MHC BINDING PEPTIDES TO ELICIT CYTOTOXIC AND HELPER T-LYMPHOCYTES FOR THE ADOPTIVE THERAPY OF CANCER
90. Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
91. Naturally processed HLA-DR9/DR53 (DRB1*0901/DRB4*0101)-bound peptides
92. CD4 + T-cells from peripheral blood of a patient with psoriasis recognize keratin 14 peptide but not ‘homologous’ streptococcal M-protein epitope
93. Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma
94. Abstract 728: Optimization of peptide vaccines to induce robust antitumor CD4 T-cell responses
95. Abstract 723: Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma
96. Corporate Governance innovation in Japan & the function of the Outside Director
97. Sustained Persistence of IL2 Signaling Enhances the Antitumor Effect of Peptide Vaccines through T-cell Expansion and Preventing PD-1 Inhibition
98. Innovative immunotherapy for nasal NK/T-cell lymphoma
99. Effects of STING stimulation on macrophages: STING agonists polarize into “classically” or “alternatively” activated macrophages?
100. Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.